Jason Hollar

Jason Hollar has served as CEO of Cardinal Health since September 2022, leading the third-largest pharmaceutical distributor in the United States with over $200 billion in annual revenue. Before Cardinal Health, Hollar was CFO of Tenneco and held senior finance roles at Becton Dickinson and Chrysler, bringing a strong financial operator's perspective to a company that needed margin discipline. Cardinal Health distributes approximately one-third of all pharmaceuticals in the U.S. and also operates a significant medical products business (surgical supplies, lab products, at-home healthcare). The pharmaceutical distribution segment generates massive revenue but thin margins (typically under 1% operating margin), while the medical segment offers higher margins but has faced inflationary cost pressures on products like gloves, gowns, and syringes. Hollar inherited a company still working through $6.6 billion in opioid settlement obligations, which had weighed on the stock for years. Under his leadership, Cardinal Health has executed a margin improvement program in the medical segment, invested in generative AI for supply chain optimization, and explored strategic alternatives for non-core assets. His decisions on pharmaceutical distribution contract renewals with large pharmacy chains, medical segment restructuring, capital allocation between buybacks and growth investments, and navigation of drug pricing legislation are the primary drivers of Cardinal Health's stock.